Skip to main content

Outcast or Evolutionary Leap? Sci-Fi Thriller Gene Zero Explores a Future Where Genetic Failure Sparks Hope

Outcast or Evolutionary Leap? Sci-Fi Thriller Gene Zero Explores a Future Where Genetic Failure Sparks Hope

In a society where genetics determines your value, what happens when you’re labeled a failure, but become the key to humanity’s survival? Juniper Vivaldi Publishing is proud to announce the release of Gene Zero, an electrifying young adult biopunk novel by Moshe Lewis. Now available in Kindle and paperback formats via Amazon, Gene Zero is a pulse-pounding exploration of science, identity, and resistance that is captivating readers across the sci-fi community.

In the not-so-distant future, society thrives on genetic perfection through the Symbiote Bonding Program—a government initiative that fuses teenagers with genetically engineered organisms to unlock enhanced abilities. But for 15-year-old Brian Park, the ceremony ends in humiliation and despair. His bond fails, branding him a "zero"—a social outcast without enhancement, stripped of future opportunities and doomed to live in shame.

However, Brian soon learns that failure is a lie. He begins to manifest astonishing powers: telekinesis, superhuman speed, and a mysterious internal voice—a rogue symbiote with its own agenda. What begins as confusion soon turns into a life-threatening revelation. Brian hasn’t failed; he’s become something different. Something dangerous. Something uncontrollable.

As Brian navigates betrayal, government secrets, and violent conflict, he realizes his “defect” could be a new step in human evolution—or a trigger for its end. With the clock ticking and factions closing in, Brian must decide whether to embrace the monster inside him or rewrite the rules of survival for everyone.

“Gene Zero was born out of my fascination with biotechnology, control, and how we assign value to people,” said Moshe Lewis, author and practicing physician. “At its core, this book is about transformation and courage. Brian’s journey mirrors the internal battle we all face: Who am I, and what do I do when the world tells me I’m not enough?”

Combining thrilling action sequences with emotional depth and scientific intrigue, Gene Zero delivers a high-concept adventure that resonates with readers of Divergent, Ender’s Game, and Renegades. Lewis creates a compelling dystopian world layered with ethical complexity, futuristic tech, and unforgettable characters, each caught in the web of a government obsessed with control.

The book’s originality lies in its deep dive into biopunk—a subgenre of science fiction focusing on genetic manipulation and synthetic biology. Lewis presents a society where artificial enhancement is a rite of passage, but questions who gets to define perfection and what happens when nature defies the system.

Early readers have praised the novel for its unique world-building and emotional impact. “Gene Zero is fast-paced, cinematic, and thought-provoking. I couldn’t put it down,” said one reviewer. “Brian Park is the kind of hero we need—flawed, brave, and relentlessly human.”

About the Author:

Moshe Lewis is not just a storyteller but also a physician with a passion for exploring how science and society intersect. His background in medicine adds a layer of realism to the genetic science depicted in Gene Zero. This is his debut fiction novel, marking the beginning of what promises to be an exciting new voice in speculative fiction.

Gene Zero is now available on Amazon in eBook and paperback formats. Sci-fi fans, book reviewers, educators, and libraries are encouraged to explore this powerful debut.

Genre: YA Science Fiction / Biopunk Thriller

ISBN: B0DXRT38DJ

Publisher: Juniper Vivaldi Publishing

Release Date: Now Available

Media Contact
Company Name: Juniper Vivaldi Publishing
Contact Person: Melanie Thompson
Email: Send Email
Phone: +1 888 280-4331
Address:4900 Lacross Rd.
City: North Charleston
State: South Carolina
Country: United States
Website: https://www.amazon.com/Gene-Zero-Biopunk-Moshe-Lewis-ebook/dp/B0DXRT38DJ

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.